Modelling the long QT syndrome with induced pluripotent stem cells
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modelling human disease and for individualizing drug testing. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death. Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I(Kr). Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K(ATP)-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Cited by
Items 701–800 of 1,000
Brugada, P., Brugada, R., Campuzano, Ó., Sarquella‐Brugada, G., Brugada, P., Brugada, V., & Brugada, J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00092-3 · Cited by 7
Molecular Insights into Short QT Syndrome
Perike, S., & McCauley, M. D. (2018) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2018.090302 · Cited by 7
Using MicroRNAs to Enhance the Generation of Induced Pluripotent Stem Cells
Li, Z., & Rana, T. M. (2012) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc04a04s20 · Cited by 7
Recapitulating Long-QT Syndrome Using Induced Pluripotent Stem Cell Technology
Dirschinger, R. J., Goedel, A., Moretti, A., Laugwitz, K., & Sinnecker, D. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0286-8 · Cited by 7
Phenotyping Patient-Derived Cells for Translational Studies in Cardiovascular Disease
Shaw, S. Y., & Brettman, A. D. (2011) · Circulation · doi:10.1161/circulationaha.111.043943 · Cited by 9
Pluripotent Stem Cells and Their Dynamic Niche
Reinwald, Y., Bratt, J. A. J., & Haj, A. J. E. (2016) · InTech eBooks · doi:10.5772/62671 · Cited by 10
The Advent of the Golden Era of Animal Alternatives
Butzke, D., Grune, B., Kugler, J., Oelgeschläger, M., Seiler, A. E. M., Sittner, D., Liebsch, M., & Luch, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00003-8 · Cited by 7
Macadangdang, J. R., Miklas, J. W., Smith, A. S. T., Choi, E., Leung, W. W., Wang, Y., Guan, X., Lee, S., Salick, M. R., Regnier, M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/456301 · Cited by 7
Congenital Long QT Syndrome: A Focus on Risk Stratification and Management
Ranganathan, D., Grondin, S., Hadjeres, R., & Joza, J. E. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm36779 · Cited by 8
Tatekoshi, Y., Chen, C., Shapiro, J. S., Chang, H., Blancard, M., Lyra‐Leite, D. M., Burridge, P. W., Feinstein, M. J., D’Aquila, R. T., Hsue, P. Y., et al. (2024) · eLife · doi:10.7554/elife.95867 · Cited by 8
Lui, K. O., Stachel, M., Lieu, D. K., Li, R. A., & Bu, L. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.09.001 · Cited by 7
Gowran, A., Rasponi, M., Visone, R., Nigro, P., Perrucci, G. L., Righetti, S., Zanobini, M., & Pompilio, G. (2016) · Stem Cells International · doi:10.1155/2016/4287158 · Cited by 7
Liew, L. C., Poh, B. M., An, Ö., Ho, B. X., Lim, C. Y. Y., Pang, J. K. S., Beh, L. Y., Yang, H. H., & Soh, B.-S. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03610-2 · Cited by 7
Butler, A. S., Ascione, R., Marrion, N. V., Harmer, S. C., & Hancox, J. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-53571-6 · Cited by 6
Stem cell models of inherited arrhythmias
Ryan, T. L., & Roberts, J. D. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00451-x · Cited by 6
Using induced pluripotent stem cells for drug discovery in arrhythmias
Teles, D., & Fine, B. M. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2360420 · Cited by 6
Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model
Sleiman, Y., Reisqs, J., & Boutjdir, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179155 · Cited by 7
Synthetic embryology of the human heart
Paredes-Espinosa, M. B., & Paluh, J. L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1478549 · Cited by 8
Databases and collaboration require standards for human stem cell research
Litterman, N. K., & Ekins, S. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.006 · Cited by 8
Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA
Dang, J. W., & Rana, T. M. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_201 · Cited by 6
Sigalas, C., Cremer, M. A., Winbo, A., Bose, S. J., Ashton, J. L., Bub, G., Montgomery, J., & Burton, R. A. B. (2020) · Royal Society Open Science · doi:10.1098/rsos.200265 · Cited by 4
Generation of Human Induced Pluripotent Stem Cells and Differentiation into Cardiomyocytes
Han, L., Mich-Basso, J. D., & Kühn, B. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0668-1_10 · Cited by 6
RNA interference-based therapeutics for inherited long QT syndrome
Li, G., Ma, S., & Sun, C. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2573 · Cited by 6
Programmatic change: lung disease research in the era of induced pluripotency
Ikonomou, L., Hemnes, A. R., Bilousova, G., Hamid, R., Loyd, J. E., Hatzopoulos, A. K., Kotton, D. N., Majka, S. M., & Austin, E. D. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00255.2011 · Cited by 6
Rawat, N., & Singh, M. K. (2017) · Veterinary World · doi:10.14202/vetworld.2017.640-649 · Cited by 8
KCNQ1 G219E and TRPM4 T160M polymorphisms are involved in the pathogenesis of long QT syndrome
Zhao, Y., Feng, M., Shang, L., Sun, H., Zhou, X., Lu, Y., Zhang, L., Xing, Q., Li, Y., & Tang, B. (2021) · Medicine · doi:10.1097/md.0000000000024032 · Cited by 6
Translational potential of hiPSCs in predictive modeling of heart development and disease
Mansfield, C., Zhao, M., & Basu, M. (2022) · Birth Defects Research · doi:10.1002/bdr2.1999 · Cited by 6
Cai, D., Zheng, Z., Jin, X., Fu, Y., Cen, L., Ye, J., Song, Y., & Lian, J. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10298-x · Cited by 6
Moon, S., Bae, D., Jung, T., Chung, E.-B., Jeong, Y.-H., Park, S., & Chung, H. (2017) · International Journal of Stem Cells · doi:10.15283/ijsc17024 · Cited by 7
Callaway, E. (2011) · Nature · doi:10.1038/469279a · Cited by 6
The state of the art in stem cell biology and regenerative medicine: the end of the beginning
Snyder, E. Y. (2017) · Pediatric Research · doi:10.1038/pr.2017.258 · Cited by 7
Modeling lung cell development using human pluripotent stem cellsPreprint
Ngan, S. Y., Quach, H. T., Dierolf, J. G., Laselva, O., Lee, J. A., Huang, E. N., Mangos, M., Xia, S., Bear, C. E., & Wong, A. P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.16.452691 · Cited by 6
Li, Q., Wang, Y., Wang, B., Lv, T., & Zhang, P. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm28251 · Cited by 6
Liu, Y., Zhang, Z., Li, H., Prados‐Martin, L., Li, H., Cheng, F., Tu, X., Lim, K. S., Li, W., & Wang, M. (2026) · Advanced Science · doi:10.1002/advs.74917 · Cited by 12
Campbell, K. A., Terzic, A., & Nelson, T. J. (2015) · Regenerative Medicine · doi:10.2217/rme.15.41 · Cited by 5
Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target
Dattani, A., Singh, A., McCann, G. P., & Gulsin, G. S. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11010012 · Cited by 6
Krogulec, E., Dobosz, A. M., Stefanowski, N., Kendziorek, M., Janikiewicz, J., & Dobrzyń, A. (2025) · Kardiologia Polska · doi:10.33963/v.phj.104577 · Cited by 5
Enhanced SMAD1 Signaling Contributes to Impairments of Early Development in CFC-iPSCs
Han, K.-M., Kim, S.-K., Kim, D., Choi, J.-Y., Im, I., Hwang, K., Kim, C., Lee, B. H., Yoo, H., & Han, Y. (2015) · Stem Cells · doi:10.1002/stem.1963 · Cited by 5
Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology
Easley, C. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9182-2_3 · Cited by 5
Multisite phosphorylation of the cardiac ryanodine receptor: a random or coordinated event?
Gaburjáková, J., Krejčíová, E., & Gaburjáková, M. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02473-3 · Cited by 5
Recent Status in Brugada Syndrome
Bayrak, F., & Brugada, P. (2022) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2022.21020 · Cited by 6
Zykaj, E., Abboud, C., Asadi, P., Warsame, S., Almousa, H. A., Milev, M. P., Greco, B. M., López‐Sánchez, M., Bratkovic, D., Kachroo, A. H., et al. (2024) · Cells · doi:10.3390/cells13171457 · Cited by 6
Induced pluripotent stem cell modeling of complex genetic diseases
Hinson, J. T., Nakamura, K., & Wu, S. M. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.04.002 · Cited by 5
Zhu, S., Cawley, S. M., Bloch, K. D., & Huang, P. L. (2013) · Cardiovascular System · doi:10.7243/2052-4358-1-10 · Cited by 5
Slotvitsky, М. М., Tsvelaya, V. A., Frolova, S. R., Dement’eva, E. V., & Игоревич, А. К. (2018) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj18.346 · Cited by 5
Genomics, Proteomics, and Metabolomics for Stem Cells Monitoring in Regenerative Medicine
Keshel, S. H., Rahimi, A., Rezaei–Tavirani, M., Sefat, F., & Khojasteh, A. (2019) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-27727-7_2 · Cited by 5
The updated view on induced pluripotent stem cells for cardiovascular precision medicine
Wang, Y., Lei, W., Yang, J., Ni, X., Ye, L., Shen, Z., & Hu, S. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02530-5 · Cited by 5
Beating in a dish: new hopes for cardiomyocyte regeneration
Gu, Y., Yi, F., Liu, G., & Belmonte, J. C. I. (2012) · Cell Research · doi:10.1038/cr.2012.163 · Cited by 5
Human pluripotent stem cell-derived cardiovascular progenitors for heart regeneration
Lui, K. O., Stachel, M., Li, R. A., & Bu, L. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.08.003 · Cited by 5
Wang, Y. (2014) · New Journal of Science · doi:10.1155/2014/756240 · Cited by 6
Dr. Thomas N. James, MD, MACP (1925–2010): In Memoriam
Giulia Ottaviani, M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.04.001 · Cited by 5
Paredes‐Redondo, A., & Lin, Y. (2019) · Wiley eBooks · doi:10.1002/9780470015902.a0028371 · Cited by 5
Vesmaker, K., Venkadakrishnan, J., & Dhar, A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178356 · Cited by 4
Pluripotent Stem Cells to Model Human Cardiac Diseases
Calvin, C., & Charles, C. (2013) · InTech eBooks · doi:10.5772/54373 · Cited by 5
Perspective from the heart: The potential of human pluripotent stem cell‐derived cardiomyocytes
Xu, X. Q., & Sun, W. Y. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24359 · Cited by 4
Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells
Ng, K., Law, C.-Y., & Tse, H. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041105 · Cited by 4
Stem and Progenitor Cells in Regenerative Pharmacology
Furth, M. E., Childers, M. K., & Reid, L. M. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139047357.008 · Cited by 4
Rebs, S., & Streckfuß‐Bömeke, K. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2023.1222986 · Cited by 4
Wali, R., Xu, H., Cheruiyot, C., Saleem, H. N., Janshoff, A., Habeck, M., & Ebert, A. (2024) · Biological Chemistry · doi:10.1515/hsz-2024-0023 · Cited by 6
Mun, D., Kang, J., Park, M., Yoo, G., Yun, N., Hwang, Y., & Joung, B. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1524909 · Cited by 4
Stem Cell Therapy to Treat Heart Failure
Földes, G., & Harding, S. E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-088504-9.00157-4 · Cited by 7
Ross, G. R., Rizvi, F., Emelyanova, L. V., Tajik, A. J., & Jahangir, A. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03030-w · Cited by 4
Yamaguchi, T., Adachi, Y., Tanida, T., Taguchi, K., Oka, Y., Yoshida, T., Kim, W., Takahashi, K., & Tanaka, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-58010-0 · Cited by 4
Sheng, W., Li, Y., Qin, C., Zhang, Z., Pan, Y., Tong, Z., Teng, C., & Wei, X. (2024) · Bio-Design and Manufacturing · doi:10.1007/s42242-024-00308-z · Cited by 4
Lu, X., Perr, E., Naqvi, T., Galitz, D., Andersen, M., Grabowski, D. C., Person, A. D., Kalyuzhny, A. E., & Flynn, K. C. (2024) · Cells · doi:10.3390/cells13181566 · Cited by 5
Advances in the development and use of human tissue-based techniques for drug toxicity testing
Clotworthy, M., & Archibald, K. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.802770 · Cited by 4
Nos3−/− iPSCs model concordant signatures of in utero cardiac pathogenesis
Campbell, K. A., Li, X., Biendarra‐Tiegs, S. M., Terzic, A., & Nelson, T. J. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.08.021 · Cited by 4
Development of a Universal RNA Beacon for Exogenous Gene Detection
Guo, Y., Lu, Z., Cohen, I. S., & Scarlata, S. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0166 · Cited by 4
Action Potential Shape Is a Crucial Measure of Cell Type of Stem Cell-Derived Cardiocytes
Bett, G. C. L., Kaplan, A. D., & Rasmusson, R. L. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2015.11.026 · Cited by 4
Stem Cells: Are We Ready for Therapy?
Schroeder, I. S. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1453-1_1 · Cited by 4
Inheritable Potassium Channel Diseases
Amin, A. S., & Wilde, A. A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00052-3 · Cited by 4
Chun, Y. W., Durbin, M. D., & Hong, C. C. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0984-9 · Cited by 5
Malik, S., & Dhasmana, A. (2021) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-78101-9_5 · Cited by 4
A New Class of Stem Cells in South Africa: Introducing Induced Pluripotent Stem cells (iPS cells)
Ballo, R., Greenberg, L. S., & Kidson, S. H. (2012) · South African Medical Journal · doi:10.7196/samj.6604 · Cited by 4
Cardiac fibrillation—challenges and evolving solutions
Nattel, S. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.133 · Cited by 4
A glimpse at cardiac ion channel macromolecular complexes
Balse, E., & Hatem, S. N. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu110 · Cited by 4
Induced Pluripotent Stem Cells from Polycystic Kidney Disease Patients
Hofherr, A., & Köttgen, M. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070767 · Cited by 4
Elucidating arrhythmogenic right ventricular cardiomyopathy with stem cells
Laurita, K. R., Vasireddi, S. K., & Mackall, J. A. (2022) · Birth Defects Research · doi:10.1002/bdr2.2010 · Cited by 3
Tumor Immune Engineering: Developing In Vitro Assays to Understand the Tumor–Immune Crosstalk
Iyer, R. N., Vartak, M., & Dey, T. (2025) · Advanced Biology · doi:10.1002/adbi.202400735 · Cited by 4
Models of the human heart for biomedical research: Opportunities and challenges
Streckfuß‐Bömeke, K., Zelarayan, L. C., Schnabel, R. B., Kränkel, N., Maack, C., Eschenhagen, T., Kappler, H. E., Klingmüller, U., Kramann, R., Loewe, A., et al. (2026) · Physiological Reports · doi:10.14814/phy2.70845 · Cited by 3
Khudiakov, A. A., Mura, M., Giannetti, F., Leonov, V., Alberio, C., Eskandr, M., Lonati, P. A., Borghi, M. O., Brink, P. A., Crotti, L., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag105 · Cited by 3
Guiding the spatial organization of engineered heart tissues
Beeghly, G. F., Shakeri, A., Mirzapourshafiyi, F., Dikyol, C., Offen, N., Alsaafin, A., Nuber, U. A., & Radisic, M. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115907 · Cited by 3
What Can hiPSC-Cardiomyocytes Teach Us about Modeling Complex Human Disease Phenotypes?
Broeckel, U. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.08.016 · Cited by 4
Current Status of Genome Editing in Cardiovascular Medicine
Termglinchan, V., Karakikes, I., Seeger, T., & Wu, J. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34148-4_7 · Cited by 4
Choi, D.-K., Kim, Y.-K., HoonYu, J., Min, S., & Park, S.-W. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.020 · Cited by 5
Induced pluripotent stem cells: progress towards a biomedical application
Barile, L., Altomare, C., & Zaza, A. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.123 · Cited by 3
Barbato, E., Lara‐Pezzi, E., Stolen, C., Taylor, A. M., Barton, P. J. R., Bartúnek, J., Iaizzo, P. A., Judge, D. P., Kirshenbaum, L. A., Blaxall, B. C., et al. (2014) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-014-9555-7 · Cited by 3
Li, G., HE, X., & Sun, C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2668 · Cited by 3
Transformation to Inducible Pluripotent Stem Cells
Kodo, K., Ong, S., & Wu, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801888-0.00020-5 · Cited by 3
Deo, M., Akwaboah, A. D., Tsevi, B., Treat, J. A., & Cordeiro, J. M. (2020) · Archives of Stem Cell and Therapy · doi:10.46439/stemcell.1.003 · Cited by 5
Application of hiPSC as a Drug Tester Via Mimicking a Personalized Mini Heart
Wei, L., Xia, S., Li, Y., Qi, Y., Wang, Y., Zhang, D., Hua, Y., & Luo, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.891159 · Cited by 3
Disruptors of AKAP-Dependent Protein–Protein Interactions
Walker‐Gray, R., Pallien, T., Miller, D. C., Oder, A., Neuenschwander, M., von Kries, J. P., Diecke, S., & Klußmann, E. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2245-2_8 · Cited by 3
Jasim, S. A., Bokov, D. O., Suksatan, W., Alsaikhan, F., Jawad, M. A., Sharma, S. K., Chupradit, S., & Thangavelu, L. P. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867330666221021122603 · Cited by 5
Saleem, H. N., Ignatyeva, N., Stuut, C., Jakobs, S., Habeck, M., & Ebert, A. (2024) · Cells · doi:10.3390/cells13110923 · Cited by 3
Gene Transfer in Cardiomyocytes Derived from ES and iPS Cells
Stillitano, F., Karakikes, I., & Hajjar, R. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6588-5_12 · Cited by 3
Multifunctional Roles of αB-Crystallin in Skeletal and Cardiac Muscle Homeostasis and Disease
Mitzelfelt, K. A., & Benjamin, I. J. (2015) · Heat shock proteins · doi:10.1007/978-3-319-16077-1_11 · Cited by 3
Zhang, J., Qu, J., & Wang, J. (2014) · Europe PMC (PubMed Central) · Cited by 6
Microelectrode Arrays in Cardiac Mapping
Meyer, T. S., Guenther, E., & Kraushaar, U. (2012) · Wiley eBooks · doi:10.1002/9781118481585.ch3 · Cited by 3
Clinical Application of Induced Pluripotent Stem Cells in Cardiovascular Medicine
Chi, H., Gao, S., Yang, X.-C., Cai, J., Zhao, W.-S., Sun, H., & Geng, Y. (2015) · Cardiology · doi:10.1159/000381280 · Cited by 5
Delineating nuclear reprogramming
Ooi, J., & Liu, P. (2012) · Protein & Cell · doi:10.1007/s13238-012-2920-x · Cited by 3
Metadata
- Authors
- Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., Boulos, M., & Gepstein, L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gepstein, Lior
- Venue
- Nature
- Published
- 2011-01-16
- Volume
- 471
- Issue
- 7337
- Pages
- 225-229
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2115644752
- Cited by
- 1,049
- References
- 28
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 46 · 2023: 27 · 2022: 53 · 2021: 68 · 2020: 47 · 2019: 55 · 2018: 60 · 2017: 71 · 2016: 87 · 2015: 97 · 2014: 84 · 2013: 111 · 2012: 123
- FWCI
- 86.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome type 2, KCNH2 mutation, induced pluripotent stem cells, iPSC-derived cardiomyocytes, action potential duration prolongation, drug screening, drug-induced arrhythmia, sudden cardiac death, calcium channel blockers, KATP channel openers, potassium channel blockers, arrhythmogenicity
- MeSH terms
- ERG1 Potassium Channel, Adult, Cells, Cultured, Drug Evaluation, Preclinical, Female, Fibroblasts, Humans, Long QT Syndrome, Models, Biological, Phenotype, Patch-Clamp Techniques, Mutation, Missense, Myocytes, Cardiac, Ether-A-Go-Go Potassium Channels, Embryonic Stem Cells, Cell Transdifferentiation, Induced Pluripotent Stem Cells, Precision Medicine, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.